What is the recommended treatment for ocular toxocariasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Ocular Toxocariasis

The recommended treatment for ocular toxocariasis is albendazole 400 mg twice daily for 2 weeks combined with corticosteroids, with joint management by an ophthalmologist. 1

Diagnosis and Clinical Presentation

  • Ocular toxocariasis presents with visual changes, retinal granuloma, or uveitis, with eosinophilia being less common in isolated ocular disease 1
  • Diagnosis is primarily through serology, with fundoscopic examination revealing whitish epiretinal lesions or scars 2, 3
  • Optical coherence tomography may show elevated retinal surfaces and posterior acoustic shadowing of scars 2

Treatment Algorithm

First-line Treatment

  • Albendazole 400 mg twice daily for 2 weeks combined with corticosteroids is the recommended regimen 1, 2
  • Corticosteroid therapy (typically prednisolone 40-60 mg once daily) should be administered to control inflammation 1, 3
  • Joint management with ophthalmology is essential for optimal outcomes 1

Treatment Protocol Details

  • Some clinicians initiate corticosteroids (oral prednisolone 0.5-1 mg/kg/day) before or concurrently with albendazole to minimize inflammatory reactions 3
  • For severe cases, higher doses of corticosteroids may be required, with triamcinolone being an alternative option (16 mg daily for 2 weeks, then 8 mg daily for 1 week) 2
  • Treatment duration should be at least 2 weeks, with monitoring for clinical improvement 1, 4

Advanced or Complicated Cases

  • In cases with significant vitreous involvement, intravitreal injections may be considered, similar to management approaches for other ocular parasitic infections 5
  • Vitrectomy should be considered in cases with significant vitreous opacity or when fungal/parasitic abscesses are inaccessible to systemic agents 5, 3
  • For cases with macular involvement, more aggressive therapy may be required 5

Monitoring and Follow-up

  • Serial fundus examinations and optical coherence tomography should be performed to monitor treatment response 2, 3
  • Combined albendazole and corticosteroid therapy has shown lower recurrence rates (17.4%) compared to corticosteroid monotherapy (54.5%) 3
  • Visual acuity should be monitored before and after therapy to assess treatment efficacy 4

Special Considerations

  • In children with idiopathic nephrotic syndrome, careful monitoring is required when administering albendazole (15 mg/kg/24h for 7 days) with concurrent increase in prednisone dosage 6
  • Screening for potential co-infections (particularly Strongyloides) is recommended before initiating prolonged corticosteroid therapy to prevent hyperinfection 1
  • Ocular toxocariasis may occur without systemic eosinophilia, making diagnosis challenging 1, 3

Prevention

  • Risk for toxocariasis can be reduced by handwashing after soil contact, routine pet deworming, and appropriate disposal of pet feces 7
  • Avoiding consumption of raw meat, especially raw cow liver, which has been significantly associated with ocular toxocariasis in adults (80.8% of cases vs. controls) 3

References

Guideline

Treatment of Toxocariasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical features and course of ocular toxocariasis in adults.

PLoS neglected tropical diseases, 2014

Research

Treatment of ocular toxocariasis with albendazole.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2001

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Ocular toxocariasis in a boy with idiopathic nephrotic syndrome - a case report].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2016

Research

Toxocariasis: A Review for Pediatricians.

Journal of the Pediatric Infectious Diseases Society, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.